[Asia Economy Reporter Park Jihwan] KemOn announced on the 5th that it has signed a research contract for toxicity testing using rodents for combination drugs worth 2.075 billion KRW.



This corresponds to 10.7% of recent sales revenue.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing